PMID: 2894380Dec 1, 1987Paper

Recent advances in pharmaceutical chemistry--review. III. A new wave of beta-blockers

Journal of Clinical Pharmacy and Therapeutics
J V Okopski

Abstract

No abstract listed.

References

Jan 1, 1986·Journal of Cardiovascular Pharmacology·H D DoshanF S Caruso
Jan 1, 1986·Journal of Cardiovascular Pharmacology·N A EstesT A Solomon
Jan 1, 1986·Journal of Cardiovascular Pharmacology·P Capone, R Mayol
Jan 1, 1986·Journal of Cardiovascular Pharmacology·R J NorrisS W Sanders
Jan 1, 1986·Journal of Cardiovascular Pharmacology·F R BühlerP Erne
Jan 1, 1986·Journal of Cardiovascular Pharmacology·I SchulzK Imamura
Jan 1, 1986·Journal of Cardiovascular Pharmacology·P WillimannH Siegenthaler
Jan 1, 1986·Journal of Cardiovascular Pharmacology·W Schiess, P Dorow
Jan 1, 1986·Journal of Cardiovascular Pharmacology·A RighettiW Rutishauser
Jan 1, 1986·Journal of Cardiovascular Pharmacology·P van BrummelenF R Bühler
Jan 1, 1986·Journal of Cardiovascular Pharmacology·J FabreA Donath
Mar 1, 1985·Anesthesia and Analgesia·P G MenkhausE Bradley
Aug 1, 1985·Journal of Hypertension·P WeidmannA Gerber
Oct 23, 1985·The American Journal of Cardiology·D T LowenthalA Staudacher
Oct 23, 1985·The American Journal of Cardiology·A M GreenspanA Laddu
Oct 23, 1985·The American Journal of Cardiology·R J Gorczynski
Oct 23, 1985·The American Journal of Cardiology·R J GrayJ M Matloff
Nov 1, 1985·Clinical Pharmacology and Therapeutics·J G Riddell, R G Shanks
Nov 1, 1985·Clinical Pharmacology and Therapeutics·C S ReillyA J Wood
Jan 1, 1985·European Journal of Clinical Pharmacology·O K AnderssonG Nyberg
Jan 1, 1986·Journal of Clinical Pharmacology·F S CarusoR Vukovich
Mar 1, 1986·Journal of Clinical Pharmacology·D SheppardA Laddu
Jul 1, 1986·Journal of the American College of Cardiology·A S IskandrianS Kane-Marsch
Jan 1, 1986·European Journal of Clinical Pharmacology·A SelenP G Welling
Nov 26, 1986·The American Journal of Cardiology·M SolimonV M Campese
Nov 26, 1986·The American Journal of Cardiology·G J Fairhurst
Oct 1, 1986·Clinical Pharmacology and Therapeutics·M Frisk-Holmberg, G Ström
Jan 1, 1986·Clinical Pharmacology and Therapeutics·P G WilcoxS G Carruthers
Nov 1, 1984·Journal of Cardiovascular Pharmacology·H J Schliep, J Harting
Jul 1, 1980·British Journal of Clinical Pharmacology·J F GiudicelliP L Morselli
Jan 1, 1983·European Journal of Clinical Pharmacology·R Palminteri, G Kaik
Sep 1, 1984·British Journal of Clinical Pharmacology·A E TattersfieldR J Bacon
Aug 1, 1984·Journal of Pharmaceutical Sciences·C Y Sum, A Yacobi
Jan 1, 1984·European Journal of Clinical Pharmacology·J W LammersC L van Herwaarden
May 1, 1983·Journal of Cardiovascular Pharmacology·U L HulthénF R Bühler
Mar 1, 1984·British Journal of Clinical Pharmacology·P D DaviesI A Campbell
Jul 1, 1984·Clinical Pharmacology and Therapeutics·R PlatzerJ Rosenthaler
Jan 1, 1982·European Journal of Clinical Pharmacology·J T Salonen, R Palminteri
Nov 16, 1963·British Medical Journal·B N PRICHARDD R LAURENCE
Jun 1, 1948·The American Journal of Physiology·R P AHLQUIST

Citations

Apr 9, 2013·Analytical Biochemistry·Leila Arjomandi-BehzadMaryam Rezazadeh
Jun 1, 1991·Cardiovascular Drugs and Therapy·D McAreaveyJ I Robertson

Related Concepts

Adrenergic beta-Antagonists

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.